Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD)
NCT00229385
Anxiety Disorders, Mental Disorders
Ramat Gan, Israel
View Trial DetailsNCT Number: NCT00269464
Evaluating the prevalence and characteristics of obsessive-compulsive (OC) symptoms in patients with chronic schizophrenia
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Sheba Medical Center
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00229385
Anxiety Disorders, Mental Disorders
Ramat Gan, Israel
View Trial DetailsNCT00001771
Anxiety Disorders, Basal Ganglia Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT01596608
Anxiety Disorders, Depressive Disorder
Toronto, Ontario, Canada
View Trial DetailsNCT06376734
Anxiety Disorders, Behavior
Sunnyvale, California, United States
View Trial Details